About iCo Therapeutics (CVE:ICO)
iCo Therapeutics Inc. (iCo) is a Canada-based biotechnology company principally focused on the identification, development and commercialization of drug candidates to treat sight-and life-threatening diseases. The Company principally focuses on in-licensing drug candidates with a clinical history, and re-dose, reformulate and develop drug candidates for the treatment of sight-and life-threatening diseases. The Company's product candidates include iCo-007, iCo-008 and an Oral AmpB Delivery System. The Company has initiated Phase II clinical trial for iCo-007. iCo-008 is a human monoclonal antibody that is offered to treat sight threatening forms of allergic conjunctivitis by neutralizing eotaxin-1, a ligand to the chemokine receptor CCR3. Oral AmpB Delivery System is a toxic option for the treatment of serious systemic fungal infections. The Company has completed pre-clinical studies for iCo's Oral AmpB Delivery System.
Industry, Sector and Symbol
Trailing P/E Ratio-4
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity-85.30%
Return on Assets-77.68%
iCo Therapeutics (CVE:ICO) Frequently Asked Questions
What is iCo Therapeutics' stock symbol?
iCo Therapeutics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ICO."
How were iCo Therapeutics' earnings last quarter?
iCo Therapeutics Inc (CVE:ICO) released its earnings results on Friday, May, 30th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.02) by $0.01. View iCo Therapeutics' Earnings History.
When will iCo Therapeutics make its next earnings announcement?
Who are some of iCo Therapeutics' key competitors?
Some companies that are related to iCo Therapeutics include Rosetta Genomics (ROSG), Sorrento Tech (ROKA), Akers Biosciences (AKR), Great Basin Scientific (GBSN), Baxano Surgical (BAXSQ), Savient Pharmaceuticals (SVNTQ), Sphere Medical (SPHR), NephroGenex (NRXGQ), Air Methods (AIRM), Alexza Pharmaceuticals (ALXA), Allos Therapeutics (ALTH), Ambit Biosciences (AMBI), Amgen Rockville (MITI), Amylin Pharmaceuticals (AMLN), Ardea Biosciences (RDEA), Ariad Pharmaceuticals (ARIA), ArthroCare (ARTC) and Asante Solutions (PUMP).
Who are iCo Therapeutics' key executives?
iCo Therapeutics' management team includes the folowing people:
- William W. Jarosz J.D., Independent Chairman of the Board
- Andrew J. Rae, President, Chief Executive Officer, Director
- W. John Meekison, Chief Financial Officer, Corporate Secretary
- Peter Hnik M.D., Chief Medical Officer
- Richard William Barker, Independent Director
- Noel F. Hall, Independent Director
- Douglas Glen Janzen, Independent Director
How do I buy iCo Therapeutics stock?
Shares of iCo Therapeutics and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is iCo Therapeutics' stock price today?
One share of iCo Therapeutics stock can currently be purchased for approximately C$0.04.
How big of a company is iCo Therapeutics?
iCo Therapeutics has a market capitalization of C$3.38 million.
How can I contact iCo Therapeutics?
iCo Therapeutics' mailing address is 760-777 Hornby St, VANCOUVER, BC V6Z 1S4, Canada. The company can be reached via phone at +1-604-6029414.
MarketBeat Community Rating for iCo Therapeutics (ICO)MarketBeat's community ratings are surveys of what our community members think about iCo Therapeutics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
iCo Therapeutics (CVE:ICO) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
iCo Therapeutics (CVE:ICO) Earnings History and Estimates Chart
iCo Therapeutics (CVE ICO) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|4/18/2018|| || || || || || || || |
iCo Therapeutics (CVE:ICO) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for iCo Therapeutics (CVE:ICO)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for iCo Therapeutics (CVE ICO)
No insider trades for this company have been tracked by MarketBeat.com
iCo Therapeutics (CVE ICO) News Headlines
No headlines for this company have been tracked by MarketBeat.com
iCo Therapeutics (CVE:ICO) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
iCo Therapeutics (CVE ICO) Stock Chart for Tuesday, January, 23, 2018